The severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) is the
etiopathogenic agent of COVID-19, a condition that has led to a formally recognized …

ABSTRACT The coronavirus disease 2019 (COVID-19), caused by the severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2), has shown a wide spectrum of clinical …

The pandemic caused by the new severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) is a worldwide public health concern. First confined in China and then disseminated …

SARS-CoV-2 is the new coronavirus responsible for COVID-19 disease. The first two cases
of COVID-19 were detected in Venezuela on March 13, 2020. The aim of this study was the …

Objectives: The first confirmed cases of COVID-19 in Cuba were reported on March 11,
2020, followed by multiple introductions of infected travelers from Europe, America, and …

Objective: this study aims to identify and characterise genomic and phylogenetically isolated
SARS-CoV-2 viral isolates in patients from Lambayeque, Peru. Methods: Nasopharyngeal …

Latin America is one of the regions in which the COVID-19 pandemic has a stronger impact,
with more than 72 million reported infections and 1.6 million deaths until June 2022. Since …

Since the zoonotic event from which SARS-CoV-2 started infecting humans late in 2019, the
virus has caused more than 5 million deaths and has infected over 500 million people …

Abstract Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), declared as a pandemic due to its …

Genome sequencing is a key strategy in the surveillance of SARS-CoV-2, the virus
responsible for the COVID-19 pandemic. Latin America is the hardest-hit region of the world …